| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |